Qpcr and Dpcr Instrumentation Market Report Overview
-
Request a Free Sample to learn more about this report
The global qPCR and dPCR instrumentation market size was USD 1242 million in 2021 and is projected to touch USD 2527.1 million by 2031, at CAGR of 7.3% during the forecast period.
The global COVID-19 pandemic has been unprecedented and staggering, with the qPCR and dPCR Instrumentation Market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
The qPCR (quantitative polymerase chain reaction) and dPCR (digital polymerase chain reaction) instrumentation market refers to the industry that provides instruments used for performing qPCR and dPCR techniques in molecular biology and genetics research. These techniques are widely used in various applications such as gene expression analysis, genotyping, pathogen detection, and biomarker discovery. QPCR and dPCR instruments are designed to amplify and detect specific DNA or RNA sequences in a sample. They offer high sensitivity, specificity, and quantitative capabilities, allowing researchers to measure the abundance of target nucleic acids accurately. These instruments typically include thermal cyclers, fluorescence detection systems, and data analysis software.
The market for qPCR and dPCR instrumentation has experienced significant growth over the years, driven by advancements in genomics research, increasing demand for personalized medicine, and expanding applications in areas such as oncology, infectious diseases, and agriculture. Key factors influencing the market include technological advancements, automation, ease of use, and the availability of cost-effective solutions.
COVID-19 Impact: Market Faced a Rise in Demand Due to Increased Diagnostic Testing during the Pandemic
There was no single sector unaffected by COVID-19. The qPCR and dPCR Instrumentation Market were affected as well. The COVID-19 pandemic led to a surge in demand for diagnostic testing worldwide. qPCR-based tests, such as RT-PCR (reverse transcription polymerase chain reaction), became the gold standard for detecting SARS-CoV-2, the virus causing COVID-19. This increased demand for qPCR instrumentation, reagents, and consumables, as labs and healthcare facilities ramped up their testing capabilities.
Latest Trends
"Introduction of Digital PCR for Better Monitoring Activities"
The qPCR and dPCR Instrumentation market is as dynamic as any market. In the market, there is everyday development to add more benefits to it. Recently, in the market, there is a digital PCR advancement in the market. Digital PCR advancements: Digital PCR (dPCR) is a rapidly evolving technology that offers absolute quantification of target DNA or RNA molecules. Recent advancements in dPCR include the development of microfluidic-based platforms, partitioning techniques, and advanced data analysis algorithms. These advancements improve sensitivity, precision, and accuracy of dPCR measurements, making it a preferred choice for applications that require precise quantification, such as rare mutation detection, copy number variation analysis, and viral load monitoring.
Qpcr and Dpcr Instrumentation Market Segmentation
-
Request a Free Sample to learn more about this report
- By Type Analysis
According to type, the market can be segmented into dPCR & qPCR.
In terms of services, dPCR is the largest segment, as it holds the maximum share of the market.
- By Application Analysis
Based on application, the market can be divided into Clinical Use, Research Use, & Other.
Driving Factors
"Increasing Application in Diagnostics Has Increased Demand in the Market"
qPCR and dPCR techniques have significant applications in molecular diagnostics. They are used for detecting and monitoring various diseases, including infectious diseases, cancer, genetic disorders, and others. The ability of qPCR and dPCR to provide highly sensitive and specific detection of nucleic acids makes them valuable tools in diagnostic testing. The increasing focus on precision medicine and personalized diagnostics further drives the demand for qPCR and dPCR instrumentation.
"Expansion of Biotechnology and Pharmaceutical Industries Has Influenced the Demand in the Market"
The biotechnology and pharmaceutical industries play a crucial role in driving the qPCR and dPCR instrumentation market. These sectors require qPCR and dPCR instruments for various applications, including drug discovery, preclinical and clinical research, and quality control. As these industries continue to grow and invest in research and development, the demand for qPCR and dPCR instruments increases. This has led to a positive impact on the qPCR and dPCR Instrumentation Market growth.
Restraining Factors
"Technical Complexity Can Lead to a Declining Trend in the Market"
qPCR and dPCR techniques require a certain level of technical expertise for experimental setup, data analysis, and result interpretation. The complexity of the techniques can be a limiting factor for researchers who may not have the necessary skills or training. This can slow down the adoption of qPCR and dPCR instruments, particularly in smaller or less specialized laboratories. As a consequence, there will be a declining trend in the qPCR and dPCR Instrumentation market.
Qpcr and Dpcr Instrumentation Market Regional Insights
-
Request a Free Sample to learn more about this report
"North America Region Dominates the Market as it Has Strong Research and Development Infrastructure "
North America has the largest qPCR and dPCR Instrumentation market share as it has a well-developed research and development infrastructure, including academic institutions, research organizations, and biotechnology hubs. These institutions actively engage in genomics research, molecular diagnostics, and related fields, driving the demand for qPCR and dPCR instrumentation. The availability of funding, expertise, and collaborative research environments in North America contribute to the market's growth. North America has been at the forefront of adopting and integrating advanced technologies in various sectors, including life sciences. The region has been quick to adopt and implement qPCR and dPCR technologies for molecular diagnostics, research, and drug development. The high level of technological awareness and willingness to embrace new advancements in the field contribute to North America's leadership in the market.
Key Industry Players
"Key Players Focus On Development of Product Portfolio for Providing Better Products to Consumers"
Key players offer a diverse range of qPCR and dPCR instruments to cater to different customer needs. They provide instrument platforms with various throughput capacities, from benchtop systems suitable for small laboratories to high-throughput systems for large-scale operations. These companies also offer a comprehensive range of reagents, consumables, and assays that are optimized for use with their instruments. The product portfolio may include integrated solutions that combine instruments, software, and assays for specific applications.
List of Market Players Profile
- Thermo Fisher(United States)
- Roche(Switzerland)
- QIAGEN(Germany)
- Bio-rad (United States)
- Agilent(United States)
- Bioer
- Biosynex
- Esco
- Analytik Jena
- Techne
- Fluidigm
- RainDance Technologies
Report Coverage
The report brings together extensive research on the qualitative and quantitative factors affecting the market. It gives an overall macro and micro view of the online reputation service industry. This research profiles a report with extensive studies on the online reputation management services market that describe the firms affecting the forecasting period. Detailed studies also offer a comprehensive analysis by inspecting factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc.
Furthermore, the post-COVID-19 pandemic’s effect on international market restrictions and a deep understanding of how the industry will recover and strategies are also stated in the report. Finally, the competitive landscape has also been examined in detail to provide clarification of the competitive landscape.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 1242 Million in 2021 |
Market Size Value By |
US$ 2527.1 Million by 2031 |
Growth Rate |
CAGR of 7.3% from 2021 to 2031 |
Forecast Period |
2024-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type and Application |
Frequently Asked Questions
-
What value is the global qPCR and dPCR Instrumentation industry expected to touch by 2031?
The global qPCR and dPCR Instrumentation industry is projected to touch USD 2527.1 million by 2031.
-
What CAGR is the qPCR and dPCR Instrumentation industry expected to exhibit during 2031?
The global qPCR and dPCR Instrumentation industry is projected to exhibit a CAGR of 7.3% over 2031.
-
What are the factors which help in pushing the qPCR and dPCR Instrumentation market?
The expansion of biotechnology and pharmaceutical industries and increasing application in diagnostics are the driving factors of the qPCR and dPCR Instrumentation market.
-
Which are the key players or most dominating companies functioning in the qPCR and dPCR Instrumentation market?
Thermo Fisher, Roche, QIAGEN, Bio-rad, Agilent, Bioer, Biosynex, Esco, Analytik Jena, Technem, Fluidigm, and RainDance Technologies are the top companies operating in the qPCR and dPCR Instrumentation market.